Peripheral artery disease (PAD) has a huge social and economic burden and is an
important contributor to the global health burden. Sex differences in PAD are apparent, with …

Background: Patients with lower extremity peripheral artery disease (PAD) are at increased
risk of major adverse cardiovascular events (MACE) and major adverse limb events (MALE) …

Focused ultrasound (FUS) has emerged as a promising noninvasive therapeutic modality for
treating atherosclerotic arterial disease. High-intensity focused ultrasound (HIFU), a …

Background Long-term cardiovascular and limb outcomes after revascularization for
peripheral artery disease and, in particular, prognosis after post-procedure major adverse …

Background: Revascularization is important for symptom treatment and limb salvage in
peripheral artery disease, yet little data exist on the incidence of post-procedure major …

Since the implementation of the Hospital Readmissions Reduction Program (HRRP),
readmissions have declined for Medicare patients with conditions targeted by the policy …

Drug-eluting stents (DES) are important additions to the armamentarium of devices used for
peripheral artery revascularization, associated with decreased rates of restenosis and target …

Objective Readmission to the hospital after revascularization for peripheral artery disease
(PAD) is frequently reported. No consensus exists as to the exact frequency and risk factors …

Importance Nationally representative estimates of hospital readmissions within 30 and 180
days after major surgery, including both fee-for-service and Medicare Advantage …

Objective Although it has been shown that patient socioeconomic status (SES) is associated
with the surgical treatments chosen for severe peripheral arterial disease (PAD), the …